Katherine Rielly-Gauvin
Director/Board Member at LIQUIDIA CORPORATION
Net worth: - $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Michael | M | 53 | 12 years | |
| Stephen Bloch | M | 62 |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 15 years |
| Joanna Horobin | M | 69 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 5 years |
| Arthur Kirsch | M | 72 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 8 years |
| Damian deGoa | M | 45 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 4 years |
| Raman Singh | M | 53 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 4 years |
| Perry Siatis | M | - | 2 years | |
| Scott Reents | M | 57 | 11 years | |
| Seth A. Rudnick | M | 75 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 16 years |
| Roger Jeffs | M | 62 | 4 years | |
| Russell Schundler | M | 49 | 3 years | |
| Michael Kaseta | M | 48 | 4 years | |
| Roxanne Austin | F | 63 | 11 years | |
| Brian L. Durkin | M | 63 | 8 years | |
| David Johnson | M | 41 | 3 years | |
| Edward Rapp | M | 66 | 11 years | |
| Steven Bariahtaris | M | 60 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 4 years |
| Jennifer Davis | F | 52 | 1 years | |
| Susan Quaggin | M | - | 1 years | |
| Tushar Shah | M | 64 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 4 years |
| Thomas Hudson | M | 62 | 8 years | |
| Richard Gonzalez | M | 70 | 11 years | |
| Frederick Waddell | M | 70 | 11 years | |
| Melody Meyer | F | 66 | 7 years | |
| Azita Saleki-Gerhardt | M | 60 | 11 years | |
| Robert Alpern | M | 73 | 11 years | |
| Brett Hart | M | 54 | 8 years | |
| Paul Manning | M | 68 | 4 years | |
| Rebecca Roberts | F | 71 | 6 years | |
| William Burnside | M | 72 | 11 years | |
| Robert Lippe | M | 59 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 9 years |
| Thomas Freyman | M | 69 | 4 years | |
| Glenn Tilton | M | 75 | 11 years | |
| Kevin Buckbee | M | 58 | 1 years | |
| Jane Woo | F | - | 3 years | |
| Rajeev Saggar | M | 50 | 2 years | |
| Nicholas Donoghoe | M | - | 5 years | |
| Scott Moomaw | M | 54 | 4 years | |
| Carrie Strom | F | - | 4 years | |
| Tim Richmond | M | 57 | 11 years | |
| Florina Gordon-Krawchick | F | 42 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 14 years |
| Todd D. Bosse | M | - | 3 years | |
| Esteban Plata | M | - | 11 years | |
| Jason Adair | M | - |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 8 years |
| Liz Shea | F | - | 11 years | |
| Roopal Thakkar | M | - | 21 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ralph Snyderman | M | 84 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | - |
| Laura Schumacher | F | 60 | - | |
| Richard D. Katz | M | 60 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 1 years |
| Timothy M. Albury | M | 55 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 6 years |
| Neal Fowler | M | 62 | - | |
| Ronald O. Robison | M | - | - | |
| Michael Severino | M | 58 | 8 years | |
| Edward Liddy | M | 78 | 9 years | |
| Roy S. Roberts | M | 84 | 3 years | |
| Carlos Alban | M | 61 | 8 years | |
| Paul Peloso | M | 66 | 5 years | |
| Elizabeth Thompson | M | 49 | 3 years | |
| Jeffrey Stewart | M | - | - | |
| Florina Krawchick | F | 42 | 1 years | |
| Peter Heerma | M | 53 | 3 years | |
| Gary Gordon | M | 71 | - | |
| Myra Rosario Herrle | M | - | 6 years | |
| Donald Frail | M | 65 | - | |
| Paul Wierbicki | M | 44 | 1 years | |
| Paul Schwichtenberg | M | 53 | 5 years | |
| Mohit Rawat | M | - | 1 years | |
| Frank A. Jaeger | M | 54 | 5 years | |
| Ron Oyston | M | 54 | 3 years | |
| Matthew Farber | M | - | - | |
| Frank Benenati | M | - | 2 years | |
| Vusi Moyo | M | - | - | |
| Nataskia Lampe | F | - | 9 years | |
| Lars Kielhorn | M | - | 3 years | |
| Chris Boone | M | - | - | |
| Mohamed Zaki | M | 59 | 4 years | |
| Gary Winer | M | 64 | 1 years | |
| Sharon Curran | F | 56 | 5 years | |
| Benjamin Maynor | M | 49 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 5 years |
| Jose Rivera | M | 58 | - | |
| Graig Suvannavejh | M | - | 1 years | |
| John Leonard | M | 66 | 1 years | |
| Janet Hammond | M | 64 | 4 years | |
| John Westwater | M | - | - | |
| Renee Tannenbaum | M | 72 | 4 years | |
| Thomas A. Hurwich | M | 63 | - | |
| David H. Donabedian | M | - | - | |
| Adelle Infante | F | - | - | |
| George Avgerinos | M | 71 | 5 years | |
| Mark Stenhouse | M | 57 | 2 years | |
| Henry Gosebruch | M | 51 | 8 years | |
| Steven N. Gersten | M | - | - | |
| Jennifer Mound Smoter | F | - | 3 years | |
| Francisco Velasco | M | 53 | 7 years | |
| Jeri Thomas | F | 63 | - | |
| Alysa Spittle | F | - | 2 years | |
| Shao Lee Lin | M | 57 | 2 years | |
| Sujay Kango | M | 60 | 1 years | |
| Maria Rivas | M | 60 | 3 years | |
| Lori-Ann Christie | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Katherine Rielly-Gauvin
- Personal Network
